Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Ending England's lockdown in December is realistic, says chief medical officer

It is realistic that England’s forthcoming national lockdown can end on Dec. 2, chief medical officer Chris Whitty said on Tuesday (Nov 3), as it is designed reduce Covid-19 transmission rates enough to move into less stringent measures.

Whitty said that any decision on whether to extend the lockdown, due to come into force on Thursday, would be for government, but he had faith that the public would adhere to the new restrictions.


Asked if there was a reliable chance of lockdown ending as scheduled on Dec. 2, Whitty said: “The aim of this is to get the rates down far enough that it’s a realistic possibility to move into a different state of play at that point in time.”

He told lawmakers that the lockdown could reduce the virus reproduction number below 1, but that other measures would be needed through the winter even if full lockdown ended in December.

Whitty and chief scientific adviser Patrick Vallance were giving evidence to a parliamentary committee ahead of a vote on Prime Minister Boris Johnson’s proposed national lockdown, due on Nov 4, which is expected to pass despite scepticism from some in Johnson’s Conservative party.

Whitty and Vallance defended the models presented to the public to justify a new national lockdown, saying it was realistic to expect that deaths from the second wave from COVID could match the first unless action were taken.

Vallance pointed out that a scenario outlined in September of the possibility of reaching 200 deaths a day, for which he was heavily criticised, had come to pass.

Whitty also criticised the so-called “Barrington Declaration”, that advocates avoiding lockdown, protecting the vulnerable and depending on “herd immunity” via natural infections.

“The basis for this is in my view, scientifically... dangerously flawed, operationally impractical and ... ethically a little difficult,” Whitty said, adding herd immunity could only be achieved with a vaccine and it would not be possible to shield the vulnerable sufficiently.

“Unfortunately these economically and socially destructive (lockdown) tools are what we’ve got, in the absence of anything else,” he said.

More For You

NHS app to boost clinical trials

The focus is on encouraging people from underrepresented groups, including minorities from African and Asian heritage, to sign up for clinical trials.

iStock

Government to use NHS app to boost clinical trials

The government’s 10-Year Health Plan is expected to provide a fillip to clinical trials, and it plans to make use of the NHS App to encourage people to sign up as participants.

People will be able to sign up for the NIHR Be Part of Research service (bepartofresearch.uk) on the NHS App for the trials best suited to their interests and needs.

Keep ReadingShow less
US pharma bets big on China to snap up potential blockbuster drugs

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies

US pharma bets big on China to snap up potential blockbuster drugs

US drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments.

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies. That compares with just two such deals in the year-earlier period, according to data from GlobalData provided exclusively to Reuters.

Keep ReadingShow less
Alliance Healthcare team raises thousands with charity bike ride to Paris

The Alliance Healthcare team

Alliance Healthcare team raises thousands with charity bike ride to Paris

Eight Alliance Healthcare team members raised over £55,000 for Theodora Children’s Charity by cycling from Surrey to Paris.

From June 13th-15th, the team took on the gruelling 300 mile cross-border Tour D’Alliance 2025 challenge and raised vital funds to support children who may be living with serious health challenges through Theodora Children’s Charity’s Giggle Doctor programme.

Keep ReadingShow less
Over four million flu vaccines across England in the 2024/25 winter flu season.

Over four million flu vaccines across England in the 2024/25 winter flu season.

CCA release

Community pharmacy administered over four million flu vaccines

Community pharmacy administered over four million flu vaccines across England in the 2024/25 winter flu season, the highest outside of the pandemic, according to the Company Chemists’ Association.

This is nearly 10 per cent higher than the number of flu vaccines administered in 2023/24.

Keep ReadingShow less
Chemotherapy-free leukaemia treatment

The trial found that a combination of two cancer drugs, ibrutinib and venetoclax, could perform better than chemotherapy among patients with chronic lymphocytic leukaemia.

iStock

Chemotherapy-free leukaemia treatment shows promise during trial

In a breakthrough in leukaemia research, scientists in the UK have tested a chemotherapy-free approach, involving a combination of targeted drugs, which may offer better outcomes.

The new treatment could radically change the way chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in adults, is treated.

Keep ReadingShow less